IP Library Granted Patent US 8,357,715
Granted Patent B2
US 8,357,715 · App. 12/751,382 · Granted Jan 22, 2013

Hetero-substituted acetanilide derivatives as analgesic agents

Inventors: John R. Carson (Norristown, PA); James J. McNally (Souderton, PA)
Assignee: Janssen Pharmaceutica, NV
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,357,715
App. No.
12/751,382
Granted
Jan 22, 2013
Kind
B2
Abstract

Hetero-substituted acetanilide derivatives are disclosed as analgesic agents. The compounds of the invention are useful in methods for treating a disease or condition in a mammal characterized by pain and/or fever.

Claims (11)

1. A method of controlling pain or fever in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a compound of Formula (I):

wherein R 3 is hydrogen and R 1 and R 2 taken together form an optionally substituted selected from the group consisting of pyarazole, and imidazole;

R 4 is a hydrogen;

n is an integer from 1 to 3;

and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

2. The method of controlling pain or fever of claim 1 , wherein R 1 and R 2 taken together form an optionally substituted imidazole and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

3. A method of controlling pain or fever in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a compound selected from the group consisting of:

5-Methyl-1H-pyrazole-3-carboxylic acid (4-hydroxy-phenyl)-amide; and

3H-Imidazole-4-carboxylic acid (4-hydroxy-phenyl)-amide;

and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

4. The method of controlling pain or fever of claim 3 , wherein the compound is 5-Methyl-1H-pyrazole-3-carboxylic acid (4-hydroxy-phenyl)-amide and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: CARSON, JOHN R.; MCNALLY, JAMES J.
To: JANSSEN PHARMACEUTICA, N.V.
Reel/Frame 048168/0296 →
Continuity (3)
Division 10778980 · Feb 13, 2004
Provisional Application 60439761 · Jan 13, 2003
Related Publication 20100204284A1 · Aug 12, 2010